Aptamers have essential advantages compared to traditional targeting molecules and antibodies: high specificity, thermal stability, high binding affinity and target discrimination, minimized batch-to-batch variation, thermal stability, decreased side effects, and lower cost of production.
Next Generation Sequencing
Next-generation sequencing (NGS) technologies are new sequencing methods for DNA and RNA sequencing. Ayass BioScience, LLC is using NGS in basic, applied, and clinical research.
Cancer Metastasis Research
Despite advancements in cancer detection, cancer that comes back or spreads still presents a challenge to oncologists. Ayass BioScience, LLC utilizes biomarkers that predict disease outcome.
Disease Prediction Using Machine Learning
Ayass Research Institute implementing machine learning models that can efficiently predict (based on our selection of biomarkers) the disease presence and progression in patients.
Spatial profiling enables deep phenotypic (Protein/RNA) profiling and mapping of those profiles to specific locations within the tissue context, giving a more precise view of molecular processes in cells and tissues.
Ayass BioScience, LLC working to find ways to better understand, treat and eventually eliminate COVID-19 and the illness that results from infection.
Experienced bioinformatics specialists at Ayass BioScience, LLC can help with any type of NGS data analysis services to turn your samples into high quality data. Services can be customized to your specific project requirements.
Epigenomics / Methylation Services: Human Genotyping Arrays, Methylation Arrays, Animal Genotyping Arrays, Plant Genotyping Arrays